24-Month Outcomes of Ahmed ClearPath(®) Glaucoma Drainage Device for Refractory Glaucoma

PURPOSE: To describe the safety and efficacy of the Ahmed ClearPath(®) (ACP) 250 mm(2) glaucoma drainage device (GDD) in the treatment of refractory primary open-angle glaucoma (POAG). PATIENTS AND METHODS: This was a retrospective, noncomparative, single-surgeon, interventional case series of adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorairaj, Syril, Checo, Leticia A, Wagner, Isabella V, Ten Hulzen, Richard D, Ahuja, Abhimanyu S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289452/
https://www.ncbi.nlm.nih.gov/pubmed/35859670
http://dx.doi.org/10.2147/OPTH.S368634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289452/
https://www.ncbi.nlm.nih.gov/pubmed/35859670
http://dx.doi.org/10.2147/OPTH.S368634

Ejemplares similares